Nickel- and Palladium-Catalyzed Cross-Coupling Reactions
FULL PAPER
1
23ajb: Rf ϭ 0.28; m.p. 136–139 °C (MeOH). – H NMR: δ ϭ 1.04 tyloxypyrimidine-5-yl)phenyl trifluoromethanesulfonate (22e)
(t, J ϭ 7.4 Hz, 6 H, 2 CH3), 1.69 (t, J ϭ 7.0 Hz, 4 H, 2 CH2), 1.88 (432 mg, 1 mmol), and PdCl2(dppf) (43 mg, 0.059 mmol) in THF,
(s, 12 H, 6 CH2), 2.00–2.15 (m, 8 H, 4 CH2), 7.20 (d, J ϭ 8.2 Hz,
4 H, C6H4), 7.41 (d, J ϭ 8.2 Hz, 4 H, C6H4). – 13C NMR: δ ϭ
14.3 (2 CH3), 52.2 (6 CH2), 12.4, 16.2, 31.1 (2 CH2), 126.4, 126.8
23ee (365 mg, 79%) was obtained according to GP 7 and sub-
sequent column chromatography (50 g of silica gel, column 15 ϫ
3 cm, PE/Et2O, 9:1), Rf ϭ 0.17; m.p. 85 °C. – IR: ν˜ ϭ 3060 cm–1,
(4 CH), 38.6, 41.4, 79.4, 81.6, 139.1, 140.2 (2 C). – C34H38 (446.7): 2925, 2906, 2855, 1600, 1542, 1455, 1343, 1025, 840, 805. – 1H
calcd. C 91.42, H 8.58; found C 91.30, H 8.65.
NMR: δ ϭ 0.83–0.98 (m, 6 H, 2 CH3), 1.29 (m, 22 H, 11 CH2),
1.42–1.58 (m, 2 H, CH2), 1.84 (quint, J ϭ 7.4 Hz, 2 H, CH2), 1.91
(s, 6 H, 3 CH2), 4.39 (t, J ϭ 6.7 Hz, 2 H, OCH2), 7.32 (d, J ϭ
8.1 Hz, 2 H, C6H4), 7.44 (d, J ϭ 8.1 Hz, 2 H, C6H4), 8.68 (s, 2 H,
Ar). – 13C NMR: δ ϭ 14.1 (2 CH3), 52.5 (3 CH2), 22.7, 22.7, 26.0,
26.7, 28.9, 29.2, 29.3, 29.4, 29.7, 29.9, 31.2, 31.8, 31.9, 67.9 (CH2),
126.9, 127.0, 147.1 (2 CH), 39.2, 41.3, 128.1, 132.4, 141.8, 164.7
(C). – MS (EI): m/z (%) ϭ 462 (25) [Mϩ], 349 (100) [Mϩ – C8H17],
311 (30), 237 (39), 207 (11), 199 (12), 180 (17), 167 (12), 149 (33),
111 (13), 91 (18), 57 (44). – C31H46N2O (462.60): calcd. C 80.46,
H 10.02, N 6.06; found C 80.49, H 10.03, N 6.14.
1-Octyl-3-(4Ј-octylbiphenyl-4-yl)bicyclo[1.1.1]pentane (23be): From
19e (2 mmol), prepared according to GP 6, 4-bromo-4Ј-octylbi-
phenyl (22b) (345 mg, 1 mmol), and PdCl2(dppf) (65 mg,
0.089 mmol) in Et2O, 23be (357 mg, 80%) was obtained according
to GP 7 and subsequent column chromatography (50 g of silica gel,
column 15 ϫ 3 cm, PE), Rf ϭ 0.34; m.p. 89 °C (MeOH). – IR: ν˜ ϭ
3030 cm–1, 2960, 2925, 2855, 1595, 1460, 1271, 1162, 1009, 822. –
1H NMR: δ ϭ 0.83–0.98 (m, 6 H, 2 CH3), 1.19–1.42 (m, 24 H, 12
CH2), 1.44–1.56 (m, 2 H, CH2), 1.90 (s, 6 H, 3 CH2), 2.63 (t, J ϭ
7.7 Hz, 2 H, CH2), 7.22 (t, J ϭ 8.0 Hz, 4 H, C6H4), 7.49 (t, J ϭ
8.0 Hz, 4 H, C6H4). – 13C NMR: δ ϭ 14.1 (2 CH3), 52.2 (3 CH2),
29.3 (2 CH2), 22.7, 26.7, 29.4, 29.4, 29.5, 29.7, 29.8, 29.9, 31.5,
31.7, 31.9, 35.6 (CH2), 126.4, 126.7, 126.9, 128.8 (2 CH), 39.1, 41.4,
138.5, 139.1, 140.4, 141.9 (C). – MS (EI): m/z (%) ϭ 444 (0.2) [Mϩ],
378 (19), 279 (21), 180 (13), 86 (54), 57 (53), 41 (100). – C33H48
(444.7): calcd. C 89.12, H 10.88; found C 89.19, H 10.84.
1-(4Ј-Ethylbiphenyl-4-yl)-3-[2-(tetrahydropyran-2-yloxy)ethyl]-
bicyclo[1.1.1]pentane (23ff): From 19f (89 mmol), prepared accord-
ing to GP 6, 22f (11.38 g, 43.6 mmol), and PdCl2(dppf) (1.30 g,
1.78 mmol) in THF, 23ff (1.605 g, 10%) and 3,3Ј-bis[2-(tetra-
hydropyran-2-yloxy)ethyl]-1,1Ј-bis(bicyclo[1.1.1]pentyl)
(1.107 g,
6.4%) were obtained according to GP 7 and subsequent column
chromatography (200 g of alumina deactivated with 5% H2O, col-
umn 30 ϫ 5 cm, hexane/EtOAc, 40:1).
5-Octyl-2-[4-(3-octylbicyclo[1.1.1]pent-1-yl)phenyl]pyrimidine
(23ce): From 19e (1.5 mmol), prepared according to GP 6, 4-(5-
23ff: Rf ϭ 0.33; m.p. 30–32 °C. – 1H NMR: δ ϭ 1.28 (t, J ϭ 7.4 Hz,
3 H, CH3), 1.48–1.75 (m, 6 H, 3 CH2), 1.75–1.95 (m, 2 H, CH2),
2.05 (s, 6 H, 3 CH2), 2.75 (q, J ϭ 7.4 Hz, 2 H, CH2), 3.45–3.65 (m,
2 H, OCH2), 3.80–4.05 (m, 2 H, OCH2), 4.68 (t, J ϭ 3.2 Hz, 1 H,
OCH), 7.22–7.37 (m, 4 H, C6H4), 7.50–7.65 (m, 4 H, C6H4). – 13C
NMR: δ ϭ 15.6 (CH3), 52.8 (3 CH2), 19.6, 25.5, 28.5, 30.8, 31.6,
62.3, 65.8 (CH2), 126.4, 126.7, 127.0, 128.2 (2 CH), 98.9 (CH), 36.9,
41.8, 138.5, 139.2, 140.1, 143.1 (C).
octylpyrimidine-2-yl)phenyl
trifluoromethanesulfonate
(22c)
(208 mg, 0.5 mmol), and PdCl2(dppf) (24 mg, 0.033 mmol) in THF,
23ce (140 mg, 63%) was obtained according to GP 7 and sub-
sequent column chromatography (25 g of silica gel, column 20 ϫ
2 cm, PE/Et2O, 19:1), Rf ϭ 0.21; m.p. 34 °C. – 1H NMR: δ ϭ 0.80–
0.96 (m, 6 H, 2 CH3), 1.33 (m, 22 H, 11 CH2), 1.48–1.56 (m, 2 H,
CH2), 1.56–1.72 (m, 2 H, CH2), 1.90 (s, 6 H, 3 CH2), 2.61 (t, J ϭ
7.6 Hz, 2 H, CH2), 7.32 (d, J ϭ 8.2 Hz, 2 H, C6H4), 8.34 (d, J ϭ
8.2 Hz, 2 H, C6H4), 8.58 (s, 2 H, Ar). – 13C NMR: δ ϭ 14.0 (2
CH3), 52.2 (3 CH2), 22.6, 22.7, 26.6, 29.0, 29.2, 29.3, 29.4, 29.6,
29.8, 30.1, 30.7, 31.7, 31.8, 31.9 (CH2), 126.2, 127.6, 156.9 (2 CH),
39.1, 41.5, 132.6, 135.5, 144.0, 162.5 (C). – MS (EI): m/z (%) ϭ 447
(34) [Mϩ ϩ H], 446 (11) [Mϩ], 432 (16) [Mϩ – CH2], 381 (38), 334
(100), 295 (33), 282 (29). – C31H46N2 (446.7): calcd. C 83.35, H
10.38, N 6.27; found C 83.28, H 10.37, N 6.24.
3,3Ј-Bis[2-(tetrahydropyran-2-yloxy)ethyl]-1,1Ј-bis(bicyclo[1.1.1]-
pentyl): Oil, Rf ϭ 0.50. – 1H NMR: δ ϭ 1.48 (s, 12 H, 6 CH2),
1.40–1.65 (m, 12 H, 6 CH2), 1.69 (t, J ϭ 7.0 Hz, 4 H, 2 CH2), 3.30
(dt, J ϭ 9.5, 7.0 Hz, 2 H, OCH2), 3.35–3.50 (m, 2 H, OCH2), 3.65
(dt, J ϭ 9.5, 6.9 Hz, 2 H, OCH2), 3.85 (ddd, J ϭ 11.4, 7.5, 3.7 Hz,
2 H, OCH2), 4.50 (t, J ϭ 3.2 Hz, 2 H, OCH). – 13C NMR: δ ϭ
49.4 (6 CH2), 19.5, 25.4, 30.1, 31.7, 62.1, 66.1 (2 CH2), 98.7 (2 CH),
36.3, 39.4 (2 C).
2-[4-(3-Octylbicyclo[1.1.1]pent-1-yl)phenyl]-5-octyloxypyrimidine
(23de): From 19e (1.5 mmol), prepared according to GP 6, 4-(5-
octyloxypyrimidine-2-yl)phenyl trifluoromethanesulfonate (22d)
(400 mg, 0.92 mmol), and PdCl2(dppf) (36 mg, 0.049 mmol) in
THF, 23de (300 mg, 70%) was obtained according to GP 7 and
subsequent column chromatography (50 g of silica gel, column 15
ϫ 3 cm, PE/Et2O, 9:1), Rf ϭ 0.26; m.p. 45 °C. – IR: ν˜ ϭ 3050
cm–1, 2960, 2930, 2860, 1613, 1577, 1548, 1442, 1285, 857, 788. –
1H NMR: δ ϭ 0.89 (t, J ϭ 6.6 Hz, 6 H, 2 CH3), 1.29 (m, 22 H, 11
CH2), 1.48–1.58 (m, 2 H, CH2), 1.83 (quint, J ϭ 6.5 Hz, 2 H, CH2),
1.91 (s, 6 H, 3 CH2), 4.08 (t, J ϭ 6.5 Hz, 2 H, OCH2), 7.31 (d, J ϭ
8.5 Hz, 2 H, C6H4), 8.26 (d, J ϭ 8.5 Hz, 2 H, C6H4), 8.44 (s, 2 H,
Ar). – 13C NMR: δ ϭ 14.0, 14.1 (CH3), 52.2 (3 CH2), 22.6, 22.7,
25.8, 26.6, 29.0, 29.1, 29.2, 29.3, 29.6, 29.8, 31.7, 31.7, 31.9, 68.7
(CH2), 126.2, 127.2, 143.6 (2 CH), 39.1, 41.5, 135.4, 143.2, 151.3,
1-(4Ј-Ethylbiphenyl-4-yl)-3-[3-(tetrahydropyran-2-yloxy)propyl]-
bicyclo[1.1.1]pentane (23fg): From 19g (115 mmol), prepared ac-
cording to GP 6, 22f (7.48 g, 28.6 mmol), and PdCl2(dppf) (1.40 g,
1.91 mmol) in THF, 23fg (6.82 g, 61%) was obtained according to
GP 7 and subsequent column chromatography (250 g of alumina
deactivated with 5% H2O, column 30 ϫ 5 cm, hexane/EtOAc, 15:1)
as an oil, Rf ϭ 0.31. – 1H NMR: δ ϭ 1.20 (t, J ϭ 6.9 Hz, 3 H,
CH3), 1.38–1.65 (m, 8 H, 4 CH2), 1.68–1.90 (m, 2 H, CH2), 1.88
(s, 6 H, 3 CH2), 2.61 (q, J ϭ 6.9 Hz, 2 H, CH2), 3.28–3.41 (m, 1
H, OCH2), 3.41–3.55 (m, 1 H, OCH2), 3.58–3.71 (m, 1 H, OCH2),
3.75–3.91 (m, 1 H, OCH2), 4.53 (t, J ϭ 3.2 Hz, 1 H, OCH), 7.11–
7.25 (m, 4 H, C6H4), 7.39–7.49 (m, 4 H, C6H4). – C27H34O2 (390.6):
calcd. C 83.03, H 8.78; found C 82.71, H 8.99.
1-{4Ј-[2-(Z)-(trans-2-Ethyloxycyclopropyl)vinyl]biphenyl-4-yl}-3-{[4-
(tetrahydropyran-2-yloxy]butyl}bicyclo[1.1.1]pentane (23gh): From
19h (2 mmol), prepared according to GP 6, 22g (170 mg,
0.5 mmol), and PdCl2(dppf) (24 mg, 0.033 mmol) in THF, 23gh
(115 mg, 48%) was obtained according to GP 7 and subsequent
column chromatography (20 g of silica gel, column 15 ϫ 2 cm, PE/
Et2O, 4:1) as an oil, Rf ϭ 0.25. – 1H NMR: δ ϭ 0.73 (q, J ϭ
157.5 (C). – MS (EI): m/z (%) ϭ 462 (30) [Mϩ], 447 (12) [Mϩ
–
CH3], 430 (18), 396 (23), 386 (20), 349 (100) [Mϩ – C8H17], 311
(20), 256 (16), 237 (17), 186 (15), 57 (72). – C31H46N2O (462.6):
calcd. C 80.46, H 10.02, N 6.06; found C 80.60, H 10.13, N 6.11.
5-[4-(3-Octylbicyclo[1.1.1]pent-1-yl)phenyl]-2-octyloxypyrimidine
(23ee): From 19e (4 mmol), prepared according to GP 6, 4-(2-oc-
Eur. J. Org. Chem. 2000, 1137Ϫ1155
1151